Published in Aliment Pharmacol Ther on April 01, 1996
Chronic sequelae of foodborne disease. Emerg Infect Dis (1997) 1.65
Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol (2001) 1.17
Features of gastritis predisposing to gastric adenoma and early gastric cancer. J Clin Pathol (2002) 1.04
Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol (2006) 0.98
Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol (2011) 0.89
Chronic gastritis. Scand J Gastroenterol (2015) 0.87
Accuracy of Helicobacter pylori serology in two peptic ulcer populations and in healthy controls. World J Gastroenterol (2008) 0.85
Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. J Infect Dis (2013) 0.82
Does gastric atrophy exist in children? World J Gastroenterol (2006) 0.79
The phenotype of gastric mucosa coexisting with Barrett's oesophagus. J Clin Pathol (2001) 0.78
Association of the Extent of Atrophic Gastritis With Specific Dyspeptic Symptoms. J Neurogastroenterol Motil (2015) 0.75
Increased Risk of Peptic Ulcers Following a Cholecystectomy for Gallstones. Sci Rep (2016) 0.75
Pathobiology of Helicobacter pylori infection. Yale J Biol Med (1999) 0.75
Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology (1982) 3.05
Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. Gastroenterology (1998) 2.62
Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J Gastroenterol (1968) 2.09
Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut (1988) 1.98
Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92
Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer (1985) 1.89
Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol (1992) 1.76
Atrophic gastritis and its sequelae. Results of 19-23 years' follow-up examinations. Scand J Gastroenterol (1974) 1.73
Studies of patients with atrophic gastritis: a 10-15-year follow-up. Scand J Gastroenterol (1966) 1.57
Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol (1991) 1.53
High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum (1994) 1.50
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology (1995) 1.49
Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Comparison with a computer-matched family sample. Scand J Gastroenterol (1979) 1.49
Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol (1996) 1.48
Gastric cancer associated structure in mucus glycoproteins shown as a clinically useful marker. Gut (1991) 1.48
Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand A (1980) 1.47
Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism (1973) 1.43
Laennec's cirrhosis with disturbed 5-hydroxytryptamine metabolism. Ann Clin Res (1969) 1.40
Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer (1983) 1.36
Plasma triglyceride metabolism in thyroid disease. J Clin Invest (1972) 1.28
Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam. Br J Clin Pharmacol (1976) 1.26
Review article: Pathogenesis of the transformation from gastritis to malignancy. Aliment Pharmacol Ther (1998) 1.23
Plasma triglyceride turnover during use of oral contraceptives. Metabolism (1971) 1.19
Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol Suppl (1991) 1.18
Active treatment of chronic neck pain: a prospective randomized intervention. Spine (Phila Pa 1976) (2000) 1.18
Decreased incidences of intestinal and diffuse types of gastric carcinoma in Finland during a 20-year period. Scand J Gastroenterol (1987) 1.16
Absorption of acetylsalicylic acid b a normal and an atrophic gastic mucosa. Scand J Gastroenterol (1969) 1.14
Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol (1990) 1.14
The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol (1985) 1.14
Long-term follow-up of subjects with superficial gastritis or a normal gastric mucosa. Scand J Gastroenterol (1971) 1.13
Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut (1989) 1.12
Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23--27 years' follow-up examinations. Scand J Gastroenterol (1978) 1.07
Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med (1976) 1.07
Metabolism of warfarin during methandrostenolone treatment. Ann Med Exp Biol Fenn (1965) 1.06
Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study. Scand J Gastroenterol (1981) 1.05
Classification principles and genetics of chronic gastritis. Scand J Gastroenterol Suppl (1987) 1.04
Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol Suppl (1985) 1.04
Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man. Atherosclerosis (1978) 1.03
Intestinal absorption and autoimmunity in endocrine disorders. Acta Med Scand (1969) 1.03
Serum ceruloplasmin concentration in rheumatoid arthritis, ankylosing spondylitis, psoriasis and sarcoidosis. Acta Rheumatol Scand (1966) 1.03
Age- and sex-related behaviour of gastric acid secretion at the population level. Scand J Gastroenterol (1982) 1.02
The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol (1991) 1.02
Epidemiology and dynamics of gastritis in a representative sample of an Estonin urban population. Scand J Gastroenterol (1982) 1.01
Clinical correlations and significance of orceinpositivity in chronic active hepatitis and primary biliary cirrhosis. Ann Clin Res (1976) 1.01
Gastrointestinal tract in hyperthyroidism before and after treatment. Scand J Gastroenterol (1966) 1.01
New aspects on epidemiology, genetics, and dynamics of chronic gastritis. Front Gastrointest Res (1980) 1.00
Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. J Clin Microbiol (1994) 0.99
An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Dig Dis Sci (1979) 0.97
Cystic "hamartomatous" epithelial polyps of the stomach. Acta Hepatogastroenterol (Stuttg) (1978) 0.97
Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer (1984) 0.97
Ultrastructure of various metaplasias of the stomach. Acta Pathol Microbiol Scand (1969) 0.97
Multicompartment analysis of the absorption kinetics of warfarin from the stomach and small intestine. Int Z Klin Pharmakol Ther Toxikol (1971) 0.96
Chronic antral gastritis, Lewis(a+) phenotype, and male sex as factors in predicting coexisting duodenal ulcer. Scand J Gastroenterol (1989) 0.95
Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. Scand J Gastroenterol (1979) 0.95
Polymorphism of plasma triglyceride kinetics in normal human adult subjects. Acta Med Scand (1971) 0.95
Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol Suppl (1991) 0.95
Lymphocyte activation in vivo in the intestinal mucosa of patients with Crohn's disease. J Clin Lab Immunol (1987) 0.93
Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut (1994) 0.93
Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemics. Atherosclerosis (1980) 0.92
Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine. Hepatology (1995) 0.92
Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacy. Int J STD AIDS (2006) 0.91
Seven-year follow-up study of chronic gastritis in gastric ulcer patients. Scand J Gastroenterol (1985) 0.91
Morphology and dynamics of the gastric mucosa in duodenal ulcer patients and their first-degree relatives. Hepatogastroenterology (1983) 0.91
Plasma endogenous triglyceride transport in hypertriglyceridaemia and effect of a hypolipidaemic drug (SU-13437). Eur J Clin Invest (1972) 0.91
Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol (1990) 0.91
Cystic 'hamartomatous' gastric polyps: a disorder of oxyntic glands. Histopathology (1983) 0.91
Progression of antral and body gastritis in patients with active and healed duodenal ulcer and duodenitis. Scand J Gastroenterol (1984) 0.90
Budesonide enema in active haemorrhagic proctitis--a controlled trial against hydrocortisone foam enema. Aliment Pharmacol Ther (1994) 0.89
Helicobacter (Campylobacter) pylori infestation and the development and progression of chronic gastritis: results of long-term follow-up examinations of a random sample. Endoscopy (1990) 0.89
Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides. Scand J Gastroenterol (1987) 0.89
Measurement of cholesterol synthesis in kinetically defined pools using fecal steroid analysis and double labeling technique in man. J Lipid Res (1977) 0.89
Chronic nonatropic ('superficial') gastritis increases the risk of gastric carcinoma. A case-control study. Scand J Gastroenterol (1994) 0.89
Characteristics of gastric mucosa which precede occurrence of gastric malignancy: results of long-term follow-up of three family samples. Scand J Gastroenterol Suppl (1991) 0.88
Kinetic analysis of triglyceride metabolism in single rats. Ann Med Exp Biol Fenn (1966) 0.88
Measurement of plasma triglyceride turnover in the study of hyperglyceridemia. Scand J Clin Lab Invest (1971) 0.87
A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG (2000) 0.87